Safety and efficacy of pertuzumab and trastuzumab in patients with HER2-Positive metastatic colorectal cancer: comparison of intravenous and subcutaneous formulations.
这项回顾性研究表明,在HER2阳性转移性结直肠癌患者中,皮下注射剂型的帕妥珠单抗和曲妥珠单抗与静脉注射剂型相比,具有相当的疗效和更低的输注相关反应发生率,同时显著缩短了治疗过程时间。